Treatment Decision Making for Older Kidney Patients during COVID-19

Abstract

Background and objectivesCoronavirus disease 2019 (COVID-19) disrupted medical care across health care settings for older patients with advanced CKD. Understanding how shared decision making for kidney treatment decisions was influenced by the uncertainty of an evolving pandemic can provide insights for supporting shared decision making through the current and future public health crises.Design, setting, participants, & measurementsWe performed thematic and narrative analyses of semistructured interviews with patients (CKD stages 4 and 5, age 70+), care partners, and clinicians from Boston, Portland (Maine), San Diego, and Chicago from August to December 2020.ResultsWe interviewed 76 participants (39 patients, 17 care partners, and 20 clinicians). Among patient participants, 13 (33%) patients identified as Black, and seven (18%) had initiated dialysis. Four themes with corresponding subthemes emerged related to treatment decision making and the COVID-19 pandemic: (1) adapting to changed educational and patient engagement practices (patient barriers to care and new opportunities for telemedicine); (2) reconceptualizing vulnerability (clinician awareness of illness severity increased and limited discussions of patient COVID-19 vulnerability); (3) embracing home-based dialysis but not conservative management (openness to home-based modalities and limited discussion of conservative management and advanced care planning); and (4) satisfaction and safety with treatment decisions despite conditions of uncertainty.ConclusionsAlthough clinicians perceived greater vulnerability among older patients CKD and more readily encouraged home-based modalities during the COVID-19 pandemic, their discussions of vulnerability, advance care planning, and conservative management remained limited, suggesting areas for improvement. Clinicians reported burnout caused by the pandemic, increased time demands, and workforce limitations, whereas patients remained satisfied with their treatment choices despite uncertainty.Clinical Trial registry name and registration number: Decision Aid for Renal Therapy (DART), NCT03522740

Best practices during COVID-19 pandemic in solid organ transplant programs in Spain

“…During the period of greatest impact of the pandemic, new and old patients assumed the organizational decisions of consultation without resistance [ 34 ]. Those who were more stable, with the longest time of post-transplant evolution and especially the furthest to the center saw in the teleconsultation a better way to assist/control their problems [ 35 ].…”

Legionella pneumophila: The Journey from the Environment to the Blood

“…The severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) disease is a pandemic that was firstly reported in Wuhan, China, in December 2019 [ 36 ]. Due to the rapid spread of the infection worldwide, the pandemic affected our everyday life and had a negative impact on healthcare services [ 37 , 38 ]. Prolonged building closures during the COVID-19 pandemic led to a stagnation in building water systems.…”

Impact of COVID-19 on Disease Self-management Among Patients With Advanced CKD: A Qualitative Study

“… 2 , 3 , 4 , 5 , 6 , 7 , 8 Barriers to self-management of kidney disease include a lack of support from care partners, inadequate knowledge about kidney disease, poor communication with health care teams, and limited health care access. 9 , 10 , 11 The coronavirus disease 2019 (COVID-19) pandemic presented an additional health threat for patients with advanced CKD, complicating self-management and increasing morbidity and mortality risks. 11 , 12 , 13 , 14 , 15 Pandemic-related restrictions further impacted patients’ access to timely, high-quality care.…”

“… 9 , 10 , 11 The coronavirus disease 2019 (COVID-19) pandemic presented an additional health threat for patients with advanced CKD, complicating self-management and increasing morbidity and mortality risks. 11 , 12 , 13 , 14 , 15 Pandemic-related restrictions further impacted patients’ access to timely, high-quality care. 11 , 16 …”